Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
  Tatva Chintan Pharma Chem Ltd
Registered Office: No 502/17 GIDC Estate,Ankleshwar , Bharuch - 393002 , Gujarat , India.
Phone : +91-75730-46951/46952   Fax:
Email :  cs@tatvachintan.com  
Website :  www.tatvachintan.com
Initial public offering of 4,616,804 equity shares of face value of 10 each ("equity shares") of Tatva Chintan Pharma Chem Limited ("the company" or the "issuer") for cash at a price of 1,083 per equity share (including a premium of 1,073 per equity share) ("offer price" aggregating to 500 Crores. The offer comprises of a fresh issue of 2,077,562 equity shares aggregating to 225 Crores ("fresh issue") and an offer for sale of 2,539,242 equity shares aggregating to 275 Crores, comprising 215,143 equity shares aggregating to 23.30 Crores by Ajaykumar Mansukhlal Patel, 751,616 equity shares aggregating to 81.40 Crores by Chintan Nitinkumar Shah, and 674,054 equity shares aggregating to 73 Crores by Shekhar Rasiklal Somani (collectively the "promoter selling shareholders") and 95,106 equity shares aggregating to 10.30 Crores by Darshana Nitinkumar Shah, 315,789 equity shares aggregating to 34.20 Crores by Priti Ajaykumar Patel, 315,789 equity shares aggregating to 34.20 Crores by Ajay Mansukhlal Patel Huf, 101,570 equity shares aggregating to 11 Crores by Kajal Shekhar Somani, 10,157 equity shares aggregating to 1.10 Crores by Shitalkumar Rasiklal Somani, and 60,018 equity shares aggregating to 6.50 Crores by Samirkumar Rasiklal Somani (collectively The "promoter group selling shareholders", and together with the promoter selling shareholders, the "selling shareholders") (the "offer for sale", and together with the fresh issue, the "offer"). The offer constitutes 20.83% of the post-offer paid-up equity share capital. Offer Price : 1083 per equity shares of face value of 10 Each. Anchor Investor offer price : 1083 per equity share. The offer price is 108.3 times the face value.

Issue Money Payable On
Opens On Closes On Application Allotment
16-Jul-21 20-Jul-21 Rs1083.00-0.00 Rs0.00-0.00
Minimum Application for shares in Nos :13  Further Multiples of :13

  RsCr Lead Managers to the Issue
Project Cost 225.00
ICICI Securities Ltd
Project Financed through Current Offer 500.00  
Post Issue Equity Share Capital 22.17  
Issue Price Rs1083.00  
 
Projects
 Funding capital expenditure requirements for expansion of its Dahej manufacturing facility General Corporate purposes
 Funding capital expenditure requirements for upgradation at its R & D facility in vadodara
Promoted By
 Ajaykumar Mansukhlal Patel
 Chintan Nitinkumar Shah
 Shekhar Rasiklal Somani
Listing At
 BSE 
 NSE 
Registrar to the Issue
 Link Intime India Pvt Ltd